Cita APA (7a ed.)
Cabanillas, M. E., Waguespack, S. G., Bronstein, Y., Williams, M., Feng, L., Sherman, S. I., & Busaidy, N. L. (5/21/2009 Supplement Part 1 of 2). Treatment (tx) with tyrosine kinase inhibitors (TKIs) for patients (pts) with differentiated thyroid cancer (DTC): The M. D. Anderson Cancer Center (MDACC) experience. Journal of Clinical Oncology, 27, 6060-6061.
Cita Chicago Style (17a ed.)
Cabanillas, M E., S G. Waguespack, Y. Bronstein, M. Williams, L. Feng, S I. Sherman, y N L. Busaidy. "Treatment (tx) with Tyrosine Kinase Inhibitors (TKIs) for Patients (pts) with Differentiated Thyroid Cancer (DTC): The M. D. Anderson Cancer Center (MDACC) Experience." Journal of Clinical Oncology 27 (5/21/2009 Supplement Part 1 of 2): 6060-6061.
Cita MLA (9a ed.)
Cabanillas, M E., et al. "Treatment (tx) with Tyrosine Kinase Inhibitors (TKIs) for Patients (pts) with Differentiated Thyroid Cancer (DTC): The M. D. Anderson Cancer Center (MDACC) Experience." Journal of Clinical Oncology, vol. 27, 5/21/2009 Supplement Part 1 of 2, pp. 6060-6061.
Precaución: Estas citas no son 100% exactas.